| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |